(Q33345369)

26 July 2017

1 reference

title

Transplantation-associated thrombotic microangiopathy: twenty-two years later (English)

1 reference

26 July 2017

Daly AS

1

1 reference

26 July 2017

Xenocostas A

series ordinal

2

1 reference

26 July 2017

Lipton JH

series ordinal

3

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

Bone Marrow Transplantation

26 July 2017

published in

1 reference

26 July 2017

volume

30

1 reference

26 July 2017

issue

11

1 reference

26 July 2017

page(s)

709-715

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703710

26 July 2017

exact match

0 references

cites work

The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

Thrombotic microangiopathy associated with reactivation of human herpesvirus-6 following high-dose chemotherapy with autologous bone marrow transplantation in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

De novo hemolytic uremic syndrome postrenal transplant after cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

Cyclosporine and tacrolimus-associated thrombotic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

Transplantation-associated thrombotic microangiopathy is associated with transplantation from unrelated donors, acute graft-versus-host disease and venoocclusive disease of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

Von Willebrand factor-cleaving protease activity and proteolysis of von Willebrand factor in bone marrow transplant-associated thrombotic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

Role of caspases 1 and 3 and Bcl-2-related molecules in endothelial cell apoptosis associated with thrombotic microangiopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

Endothelial cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

Cyclosporine inhibits endothelial cell prostacyclin production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

A new model of renal microvascular endothelial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

Porcine hematopoietic cell xenotransplantation in nonhuman primates is complicated by thrombotic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

Chemotherapy-induced hemolytic uremic syndrome: description of a potential animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Members of the Canadian Apheresis Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

Plasma exchange and vincristine in the treatment of hemolytic uremic syndrome/thrombotic thrombocytopenic purpura associated with bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

Apheresis in grade 4 bone marrow transplant associated thrombotic microangiopathy: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

Questionable efficacy of plasma exchange for thrombotic thrombocytopenic purpura after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

Plasminogen activator inhibitor (PAI-1) antigen levels in primary TTP and secondary TTP post-bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: balance between growth and death signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

Defibrotide Protects Endothelial Cells, but not L929 Tumour Cells, from Tumour Necrosis Factor-α-mediated Cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

A case of hemolytic uremic syndrome improved with nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

Protective effect of defibrotide on perfusion induced endothelial damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

7 January 2021

Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation. Gruppo Italiano Trapianto Midollo Osseo (GITMO)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

7 January 2021

Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thromboses and tubular injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

7 January 2021

Cyclosporine-associated thrombotic microangiopathy in renal allografts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

7 January 2021

Mycophenolate mofetil in cyclosporin-associated thrombotic microangiopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

7 January 2021

Management of thrombotic microangiopathy following allogeneic transplantation: what is the role of plasma exchange?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

7 January 2021

Therapeutic plasma exchange in patients suffering from thrombotic microangiopathy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

7 January 2021

Effect of recombinant human erythropoietin on endothelial cell apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

7 January 2021

Defibrotide as a promising treatment for thrombotic thrombocytopenic purpura in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703710

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1703710

1 reference

Dimensions Publication ID

26 July 2017

1008363585

0 references

1 reference